Back to search

Peptide record

TPDB92259

Pep Antibacterial Anticancer Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92259
Pep
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
dbAMP Peptipedia CancerPPD 2.0
standard
No
A 21-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from dbAMP, Peptipedia, and CancerPPD 2.0, with an available 3D structural model.
C-terminal: Amidation
Sequence
GKLRLIKKLWVKKWKKKGWKA-NH2
Physicochemical Analysis
C129H216N36O22
NDCEQHMFPSTY
K
2623.36
12.00
10
0
9
+10
2.10
-1.010
92.86
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
16500
628.96
0
Residue Composition
number
1
A
1
R
0
N
0
D
0
C
0
E
0
Q
2
G
0
H
1
I
3
L
9
K
0
M
0
F
0
P
0
S
0
T
3
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 3 K: 9 M: 0 F: 0 P: 0 S: 0 T: 0 W: 3 Y: 0 V: 1
Chemical Descriptors
21
C129H216N36O22
2623.36
12.00
+10
2.10
-1.010
Amidation
L
Linear
Free
Antimicrobial and Anticancer
Synthetic
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 = 4 µM
Anticancer
4 µM

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2021

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 2 µM
Anticancer
2 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2021